ZEN-3694

N/A

Report date: 2026/05/09 20:00:18
NME

Base Information

Drug NameZEN-3694
Drug Alias NameZEN-003694ZEN-3694
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitors
TargetsBromodomain and extra terminal domain protein
Therapy Area/IndicationsSolid tumoursLarge intestine neoplasmProstatic Neoplasms, Castration-Resistant +[18] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSpain +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZenith Epigenetics
China Registration ClassN/A

Develop Information

Active CompaniesZenith Epigenetics LtdCencora IncZenith Epigenetics +[6] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantProstatic Neoplasms +[16] 
Inactive IndicationsLarge intestine neoplasmNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A